STOCK TITAN

BD to Announce Fiscal 2023 Fourth Quarter and Full Year Financial Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags
Rhea-AI Summary
BD (Becton, Dickinson and Company) will report its fiscal 2023 Q4 and full year financial results on November 9, 2023.
Positive
  • BD will release its fiscal 2023 Q4 and full year financial results on November 9, 2023.
Negative
  • None.

FRANKLIN LAKES, N.J., Oct. 12, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that it will report its fiscal 2023 fourth quarter and full year financial results on Thursday, November 9, 2023. A news release will be issued at approximately 6:30 a.m. Eastern Time (ET) and will be available at www.bd.com/investors, along with related presentation materials. The news release and presentation materials will include summary financial information for the company's fiscal 2023 fourth quarter and full year financial results, which ended on Saturday, September 30, 2023. 

BD management will host an audio webcast at 8 a.m. ET on November 9, 2023 to discuss its financial results and provide an update on its operations and strategy. The audio webcast can be accessed at BD's investor relations website at www.bd.com/investors and a replay will be available shortly after the call at the same website.

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 77,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.

Contacts:

Media:       

Investors:

Troy Kirkpatrick                           

Adam Reiffe

VP, Public Relations                 

Sr. Director, Investor Relations

858.617.2361                               

201.847.6927           

troy.kirkpatrick@bd.com              

adam_reiffe@bd.com  

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bd-to-announce-fiscal-2023-fourth-quarter-and-full-year-financial-results-301955274.html

SOURCE BD (Becton, Dickinson and Company)

FAQ

When will BD report its fiscal 2023 Q4 and full year financial results?

BD will report its fiscal 2023 Q4 and full year financial results on November 9, 2023.

Where can I access the news release and presentation materials?

The news release and presentation materials will be available at www.bd.com/investors.

What is the date of the fiscal year end for BD's financial results?

BD's fiscal year ended on September 30, 2023.

Will there be an audio webcast to discuss the financial results?

Yes, BD management will host an audio webcast on November 9, 2023 at 8 a.m. ET to discuss the financial results and provide an update on its operations and strategy.

Where can I access the audio webcast?

The audio webcast can be accessed at BD's investor relations website at www.bd.com/investors.

Becton, Dickinson and Co.

NYSE:BDX

BDX Rankings

BDX Latest News

BDX Stock Data

68.54B
288.20M
0.31%
89.29%
1.01%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
FRANKLIN LAKES

About BDX

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others.